跳至主要内容
临床试验/CTRI/2020/08/027280
CTRI/2020/08/027280尚未招募2 期

A study to evaluate the duration of post operative analgesia using nalbuphine or butorphanol as adjuvant to intrathecal 0.5% bupivacaine compared to 0.5% bupivacaine alone in lower segmemt cesarean section

SGRDIMSAR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients who are willing to undergo the study.
  • 2.Patients undergoing elective LSCS
  • 3.Patients American Society of Anesthesiology (ASA) Grade II

排除标准

  • 1.Patient refusal
  • 2.Patient with Cardiorespiratory problems
  • 3.Patient with Coagulopathy
  • 4.Patient with Neurological disease
  • 5.Patient with Psychological disease
  • 6.Patient with Endocrine disease and allergy to used drugs
  • 7.Contraindication to drugs.
  • 8.Complicated pregnancy.

研究者

发起方
SGRDIMSAR

相似试验